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E-mail address: antonio.gomez@ehu.es (A. GomezWe previously demonstrated that ceramide-1-phosphate (C1P) stimulates ﬁbroblast and macro-
phage proliferation, but the mechanisms involved in this action have only been partially described.
Here we demonstrate that C1P induces translocation of protein kinase C-alpha (PKC-a) from the sol-
uble to the membrane fraction of bone marrow-derived macrophages. Translocation of this enzyme
was accompanied by its phosphorylation on Ser 657 residue. Activation of PKC-awas independent of
prior stimulation of phosphatidylinositol-dependent or phosphatidylcholine-dependent phospholi-
pase C activities, but required activation of sphingomyelin synthesis. Inhibition of PKC-a activation
also blocked C1P-stimulated macrophage proliferation indicating that this enzyme is essential for
the mitogenic effect of C1P.
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction prosurvival PI3-K/PKB pathway [1], and stimulation of nitric oxideCeramide 1-phosphate (C1P) is a bioactive sphingolipid that
regulates critical biological functions including, apoptosis [1–3],
phagocytosis [4,5], inﬂammation [6,7], and cell proliferation [8–
10]. A major mechanism by which C1P stimulates cell division in
macrophages involves activation of the phosphoinositide 3-kinase
(PI3-K)/protein kinase B (PKB, also known as Akt), mitogen-acti-
vated protein kinase kinase (MAPKK)/extracellularly regulated
(ERK) 1-2, and c-Jun N-terminal kinase (JNK) pathways [8]. Con-
cerning inhibition of apoptosis, we found two major mechanisms
whereby C1P exerts this action: (i) direct inhibition of acid sphin-
gomyelinase, a signal-activated enzyme that generates ceramide
from sphingomyelin [2], and (ii) inhibition of serine palmitoyl-
transferase, which is the key regulatory enzyme of the de novo cer-
amide synthesis pathway [11]. Inhibition of either of these
enzymes causes potent reduction in the levels of proapoptotic
ceramides thereby blocking apoptosis. In addition, C1P can con-
tribute to the inhibition of apoptosis through stimulation of thechemical Societies. Published by E
K, extracellularly regulated
al kinase; MAPK, mitogen-
ny stimulating factor; PBS,
kinase; PKB, protein kinase
DM, bone marrow-derived
-Muñoz).production through stimulation of the inducible form of nitric
oxide synthase [3]. Other actions of C1P that might be important
for controlling cell proliferation, or apoptosis, are stimulation of
intracellular calciummobilization, or calcium entry from the extra-
cellular milieu [12–14]. However, it should be pointed out that
these actions are likely to be cell type speciﬁc, as C1P failed to alter
calcium levels in macrophages, neutrophils, or A549 lung carci-
noma cells [9,10]. More recently, C1P was found to potently stim-
ulate cell migration [15]. The latter work was performed using
macrophages as the experimental system, a fact that is particularly
important because these cells are associated to the inﬂammatory
response, which is partly controlled by C1P [16,17].
In the present work, we demonstrate that C1P stimulates trans-
location of protein kinase C-alpha (PKC-a) from the cytosol to the
cell membranes, and that this action is essential for the stimulation
of cell proliferation by C1P.2. Materials and methods
2.1. Materials
Ceramide 1-phosphate (from bovine brain, containing predom-
inantly stearic and nervonic acids), culture medium RPMI 1640,
tricyclodecan-9-yl xanthogenate (D609), L-a-phosphatidylcholine
and dequalinium were from Sigma–Aldrich. Fetal bovine serumlsevier B.V. All rights reserved.
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man. [Methyl-3H] thymidine and [Methyl-3H] choline were from
Perkin–Elmer. The U73122 inhibitor was supplied by Tocris. Anti-
bodies to phosphoprotein kinase B (p-PKB; Ser 473), phospho-
ERK 1-2 (Thr 202/Tyr 204), PKB, ERK 1-2, and goat anti-rabbit
IgG horseradish peroxidase secondary antibody were purchased
from Cell Signalling, and those to phosphoprotein kinase C-a (p-
PKC-a; Ser 657), and b-actin (H-196) were from Santa Cruz Bio-
technology. 4b-Phorbol 12-myristate 13-acetate (PMA), and the
Protein Kinase C kit were all from Calbiochem.
2.2. Cell culture
BMDMwere isolated from femurs of 6–8-week old female CD-1
mice as described [18]. Cells were plated for 24 h in RPMI 1640
medium containing 10% FBS and 10% L-cell conditioned medium
as the source of macrophage-colony stimulating factor (M-CSF)
[19]. The non-adherent cells were removed and cultured for 4–
6 days in the same medium until about 80% conﬂuence was
reached, at which point they were used in experiments.
2.3. Delivery of C1P to cells in culture
An aqueous dispersion of natural C1P (in the form of liposomes)
was added to cultured macrophages as previously described [1,2].
Stock solutions were prepared by sonicating C1P (1 mg) in sterile
nanopure water (1 ml) on ice using a probe sonicator until a clearFig. 1. C1P stimulates PKC-a translocation. BMDMs were pre-incubated for 24 h in 1.5
fractions of BMDM. Macrophages were treated with C1P (50 lM) for the indicated times
experiment. (B) Results of scanning densitometry of the exposed ﬁlms. Data are expresse
two replicate experiments. (C and D) BMDMs were treated with C1P (50 lM) or PMA
Calbiochem according to the manufacturer’s instructions. Results are expressed as fold s
experiments performed in duplicate for panel C (*P < 0.05; **P < 0.01), and means ± S.E.Mdispersion was obtained. Final concentration of the stock solution
was approximately 1.47 mM. We believe this procedure is prefer-
able to dispersions created by adding C1P in organic solvents be-
cause droplet formation is minimized and there are no solvent
effects on cells.
2.4. Determination of DNA synthesis
BMDM were seeded at 500 000 cells/well in 12-well plates and
they were grown in the medium indicated above. Before experi-
ments, macrophages were pre-incubated for 24 h in RPMI 1640
with 10% FBS and 1.5% L-cell conditioned medium (as the source
of M-CSF) and then incubated in the presence or absence of ago-
nists for 24 h. [3H]Thymidine (0.5 lCi/ml) was added for the last
2 h of incubation. The medium was then removed and cells were
washed twice with phosphate-buffered saline (PBS). [3H]Thymi-
dine incorporation into DNA was measured as described previously
[8–10].
2.5. Western blotting
Macrophages were harvested and lysed in ice-cold homogeniza-
tion buffer as described [18]. Twenty to 40 lg of protein from each
sample were loaded and separated by SDS–PAGE, using 12% sepa-
rating gels. Proteins were transferred onto nitrocellulose paper and
blocked for 1 h with 5% skim milk in Tris-buffered saline (TBS)
containing 0.01% NaN3 and 0.1% Tween 20, and then incubated% L-cell conditioned medium. (A) Levels of PKC-a in the microsomal and soluble
. Results are representative of one experiment and were conﬁrmed in an additional
d as arbitrary units of intensity relative to control value and are the means ± S.D. of
(100 nM) for 15 min. PKC activity was determined using a commercial kit from
timulation relative to control value and are the means ± S.E.M. of ﬁve independent
. of three independent experiments performed in duplicate for panel D.
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After three washes with TBS/0.1% Tween 20, membranes were
incubated with horseradish peroxidase-conjugated secondary anti-
body at 1:5000 dilution for 1 h. Bands were visualized by enhanced
chemiluminescence.
2.6. Determination of PKC-a translocation by Western blotting
Macrophages were harvested and lysed in ice-cold homogeniza-
tion buffer as described [18]. Nuclei were then removed by centri-
fugation at 500g for 5 min, and then the membrane and soluble
fractions were separated by centrifugation at 100 000g at 4 C
for 30 min. Ten to 30 lg of protein from each sample were loaded
and separated by SDS–PAGE, using 12% separating gels, and ana-
lyzed as indicated above.Fig. 2. C1P stimulates PKC-a phosphorylation. Involvement of PKC-a in C1P-induced DNA
for the indicated times. Phosphorylation of PKC-a was examined by immunoblotting a
antibody to b-actin. Similar results were obtained in each of three replicate experiment
arbitrary units of intensity relative to control value and are the means ± S.E.M. of three rep
treated with vehicle (Ctrl) or dequalinium (1 lM) in the presence or absence of C1P (5
described in Section 2. Equal loading of protein was monitored using a speciﬁc antibody
Results of scanning densitometry of the exposed ﬁlms. Data are expressed as arbitrary un
experiments (*P < 0.05). (E) BMDMs were pre-incubated for 24 h in 1.5% L-cell conditi
presence or absence of C1P (50 lM) for 24 h, as indicated. The incorporation of [3H]thym
fold stimulation relative to the control value without inhibitor, and are the means ± S.E2.7. Determination of protein kinase C activity
Protein kinase C activity was analyzed using a Protein Kinase
Non-Radioactive kit from Calbiochem, according to the manufac-
turer’s instructions.
2.8. Measurement of inositol phosphate accumulation
These experiments were performed as previously described
[20]. Brieﬂy, the macrophages were labeled with myo-[3H]inositol
(1.5 lCi/ml) for 24 h in RPMI 1640 with 10% FBS and 1.5% L-cell
conditioned medium (as the source of M-CSF). The cells were then
washed and treated for 2.5 h with 10 mM LiCl, and after this time
they were incubated in the presence or absence of agonists for
15 min. Incubations were ended by removing the medium andsynthesis. (A) BMDMs were pre-incubated as in Fig. 1 and treated with C1P (50 lM)
s described in Section 2. Equal loading of protein was monitored using a speciﬁc
s. (B) Results of scanning densitometry of the exposed ﬁlms. Data are expressed as
licate experiments. (C) BMDMwere pre-incubated as previously indicated, and then
0 lM) for 10 min. Phosphorylation of PKC-a was examined by immunoblotting as
to b-actin. Similar results were obtained in each of three replicate experiments. (D)
its of intensity relative to control value and are the means ± S.E.M. of three replicate
oned medium, and were then treated with vehicle or dequalinium (1 lM) in the
idine into DNA was determined as indicated in Section 2. Results are expressed as
.M. of four independent experiments performed in triplicate. (**P < 0.01).
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phosphates were separated by ion exchange chromatography on
a Dowex AG1 X 8 column or eluted together, as previously de-
scribed [20]. Radioactivity in the inositol phosphate fractions was
measured by liquid scintillation counting.
2.9. Measurement of [3H] choline-labeled sphingomyelin levels
Levels of [3H]sphingomyelin were determined as described [21].
Brieﬂy, the macrophages were labeled with [methyl-3H] choline
chloride (0.5 lCi/ml) for 48 h in RPMI 1640 with 10% FBS and
1.5% L-cell conditioned medium (as the source of M-CSF). After this
time, BMDM were washed with PBS and incubated for another 2 h.
The cells were then incubated in the presence or absence of ago-
nists for the indicated times, and harvested in distilled water. Lip-
ids were extracted with 2.5 ml of chloroform/methanol (2:1, v/v).
Total lipid extracts were subject to mild alkaline hydrolysis as de-
scribed [22] and [3H]sphingomyelin was determined by thin-layer
chromatography analysis in chloroform/methanol/acetic acid/H2O
(50:30:8:5, v/v/v/v), followed by scraping and counting the radio-
activity by liquid scintillation counting.
2.10. Determination of sphingomyelin synthase (SMS) activity
SMS activitywas performed as previously described [21]. Brieﬂy,
the macrophages were harvested and lysed in ice-cold homogeni-
zation buffer containing 250 mM sucrose, 5 mM HEPES, pH 7.4,
1 mM phenylmethylsulfonyl ﬂuoride, 10 lg/ml leupeptin and
10 lg/ml aprotinin, by 15 passages through a 25-gauge  0.5-in
needle. The cell lysates were centrifuged at 1000g for 10 min at
4 C to remove the nuclei. Protein in the supernatants was quanti-
ﬁed using a commercial kit of BioRad. SMS activity was determined
using 30–40 lg protein per assay. Samples were pre-incubated for
10 min at 30 C in a ﬁnal volume of 50 ll of a solution containing
50 mM Tris–HCl, pH 7.4, 25 mM KCl, and 0.5 mM EDTA. The reac-
tion was started by adding 2 nmol of NBD C12-ceramide and
12 nmol of phosphatidylcholine, and was allowed to proceed for
30 min. The reaction was stopped by the addition of 200 ll of chlo-
roform/methanol (1:1, v/v). Lipids were extracted and NBD-sphin-
gomyelin was separated by thin-layer chromatography analysis in
chloroform/methanol/15 mM anhydrous CaCl2 (90:52.5:12, v/v/v/
v) and eluted with three washes of 3 ml of chloroform/methanol/Fig. 3. PI-PLC is not involved in C1P-induced DNA synthesis. (A) BMDMs were pre-incub
U73122 (1 lM) for 30 min prior to addition of vehicle or C1P (50 lM) for 24 h. The incorp
are expressed as fold stimulation relative to the control value without inhibitor, and show
does not increase inositol phosphate (IP) levels. BMDMs were pre-incubated as above an
determined as indicated in Section 2; all assays were performed simultaneously with s
adrenal glands(empty bars) in which angiotensin-II (Ang-II, 10 nM) was used as positive
are expressed as fold stimulation relative to the control value, and show the means ± S.E
about 1490 ± 342 dpm (means ± S.E.M., n = 3) per million of cells.acetic acid/water (50:39:1:1, v/v/v/v). The silica gel was removed
by centrifugation, and all supernatants were pooled. One milliliter
of water was added to separate the phases. The organic phase
was washed once with 1 ml of methanol/water (1:1, v/v) and
NBD-sphingomyelin was quantiﬁed by ﬂuorometric analysis.
2.11. Statistical analyses
Results are expressed as means ± S.E.M. of three independent
experiments performed in triplicate, unless indicated otherwise.
Statistical analyses were performed using Student’s t-test as appro-
priate, with the level of signiﬁcance set at P < 0.05.
3. Results and discussion
We previously found that C1P-stimulated cell division in mac-
rophages involved activation of protein kinase B (PKB or Akt),
ERK1-2 and JNK [8]. We now demonstrate that a major factor lead-
ing to stimulation of cell proliferation is activation of conventional
PKC-a. It is known that conventional PKC isoforms require their
recruitment to cell membranes for activation. Fig. 1A shows that
C1P causes a signiﬁcant increase in the level of PKC-a in the mem-
brane fraction after 15 min of incubation with C1P, at a concentra-
tion (50 lM) that is optimal for stimulation of cell proliferation [8].
However, a corresponding decrease in the levels of PKC-a in the
soluble fraction could not be detected by Western blotting. This
was probably due to the high concentration of this enzyme in
the cytosol. Therefore, to ensure that PKC-a decreased in the solu-
ble fraction, the activity of PKC was measured after 15 min of treat-
ment with C1P. Fig. 1C shows that C1P signiﬁcantly decreased PKC
activity in the cytosolic fraction, and this was in agreement with
the increased activity of PKC-a observed in the membrane fraction
(Fig. 1D). This effect of C1P was reproduced by the phorbol ester
4b-phorbol 12-myristate 13-acetate (PMA), a well-known activator
of PKC (Fig. 1C and D).
It is well established that optimal catalytic output of PKC iso-
forms requires phosphorylation on their activation loops. In partic-
ular, Ser 657 is a critical site for phosphorylation of PKC-a because
it controls the accumulation of phosphate at other sites on PKC-a
[23]. Therefore, we tested whether C1P was able to induce phos-
phorylation of this important site of PKC-a. Fig. 2A and B shows
that C1P promoted phosphorylation of PKC-a at Ser 657 in a timeated for 24 h in 1.5% L-cell conditioned medium, and then treated with or without
oration of [3H]thymidine into DNA was determined as indicated in Section 2. Results
the means ± S.E.M. of four independent experiments performed in triplicate. (B) C1P
d then treated with or without C1P (50 lM) for 10 min as indicated. IP levels were
amples obtained from BMDM (solid bars) and cells from the zona glomerulosa of
control to ensure that the method was sensitive and working appropriately. Results
.M. of three independent experiments performed in triplicate. Basal IP levels were
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incubation. As expected, phosphorylation of PKC-a was sensitive
to inhibition by the selective inhibitor dequalinium (Fig. 2C and
D). Since C1P stimulates cell division, and activation of PKC-a is in-
volved in mitogenesis, experiments were aimed at elucidating
whether phosphorylation of PKC-a was relevant for the stimula-
tion of cell growth by C1P. We and others have previously sug-
gested that primary cultures are the best model to study the
mechanisms involved in the regulation of macrophage prolifera-
tion. However, transfection of BMDM is highly inefﬁcient ([24]
and our unpublished work). Therefore, chemical inhibitors are usu-
ally used to study the contribution of speciﬁc effectors or pathways
to macrophage growth. The implication of PKC-a in the mitogenic
effect of C1P was evaluated by preincubating the cells in the pres-
ence or absence of dequalinium. This inhibitor completely blocked
the stimulation of DNA synthesis by C1P, as determined by the
incorporation of [3H]thymidine into DNA, thereby demonstrating
that phosphorylation of PKC-a at Ser 657 is essential for the mito-
genic effect of C1P (Fig. 2E).Fig. 4. C1P increases sphingomyelin (SM) levels and DNA synthesis. (A) BMDMs were pr
added for 10 min. SM levels were measured as indicated in Section 2. Results are expresse
independent experiments performed in triplicate. Basal SM levels were 7358 ± 793 dpm
DNA synthesis. BMDMs were treated with or without D609 (20 lM) for 30 min prior to a
into DNA was determined as indicated in Section 2. Results are expressed as fold stimulat
independent experiments performed in triplicate. (*P < 0.05). (C) Involvement of SM
Phosphorylation of PKC-a was examined by immunoblotting as described in Section 2. E
results were obtained in each of three replicate experiments. (D) Results of scanning de
relative to control value and are the means ± S.E.M. of three replicate experiments (*P <It is well established that diacylglycerol (DAG) is the physiolog-
ical activator of conventional and novel PKCs, including PKC-a.
DAG can be produced after stimulation of a variety of signal-acti-
vated enzymes, including different phospholipases. A major phos-
pholipase involved in PKC activation is phosphatidylinositol
speciﬁc phospholipase C (PI-PLC), which generates DAG and inosi-
tol phosphates directly by degrading phosphatidylinositol (PI).
However, inhibition of this enzyme with the selective inhibitor
U73122 did not signiﬁcantly alter C1P-stimulated DNA synthesis
(Fig. 3A). In addition, C1P did not change the levels of inositol phos-
phates (Fig. 3B), and intracellular Ca2+ levels remained unchanged
after treatment with C1P, as previously reported [8]. Activation of
PKC-a could also occur through generation of DAG by a phosphati-
dylcholine-speciﬁc phospholipase C (PC-PLC), which would
produce phosphocholine in addition to DAG. However, C1P did
not cause signiﬁcant accumulation of phosphocholine in the
macrophages, suggesting that PC-PLC activity was unaltered (data
not shown). Another enzyme capable of generating DAG is
sphingomyelin synthase (SMS), which catalyzes the transfer ofe-incubated for 24 h in 1.5% L-cell conditioned medium, and then C1P (50 lM) was
d as fold stimulation relative to the control value, and are the mean ± S.E.M. of three
(means ± S.E.M., n = 3) per million cells (B) Involvement of SMS in C1P-stimulated
ddition of vehicle (Ctrl) or C1P (50 lM) for 24 h. The incorporation of [3H]thymidine
ion relative to the control value without inhibitor, and are the means ± S.E.M. of four
S in C1P-induced PKC-a phosphorylation. BMDMs were treated as in panel B.
qual loading of protein was monitored using a speciﬁc antibody to b-actin. Similar
nsitometry of the exposed ﬁlms. Data are expressed as arbitrary units of intensity
0.05).
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ing sphingomyelin (SM). Fig. 4A shows that C1P increased SM lev-
els after challenging the macrophages with C1P for 10 min. As
expected, the activity of SMS was signiﬁcantly increased [enzyme
activity was enhanced by about 18.6 ± 2.0%, mean ± S.E.M. of three
independent experiments performed in triplicate (**P < 0.01) over
control values after treatment with C1P for 10 min]. To evaluate
whether this enzyme activity was involved in the stimulation of
cell proliferation by C1P we used tricyclodecan-9-yl-xanthogenate
(D609), a compound initially shown to inhibit PC-PLC but that is a
potent inhibitor of SMS [21,25]. Fig. 4B and C shows that D609
completely blocked the incorporation of [3H]thymidine into DNAFig. 5. Involvement of PKC activity in C1P-stimulated ERK 1-2 and PKB phosphorylation.
were pre-incubated in the presence or absence of PMA (100 nM) overnight and then treat
from Calbiochem according to the manufacturer’s instructions. Results are expressed
independent experiments performed in duplicate. (B) BMDM were treated for 16–18
Phosphorylation of ERK 1-2 and PKB was examined by immunoblotting as described in
total ERK 1-2 and PKB. Similar results were obtained in each of three replicate experimen
arbitrary units of intensity relative to control value and are the means ± S.E.M. of three re
dequalinium (1 lM) prior to addition of C1P (50 lM) for 10 min. Phosphorylation of ER
loading of protein was monitored using speciﬁc antibodies against total ERK 1-2 and PKB
scanning densitometry of the exposed ﬁlms. Data are expressed as arbitrary units of
experiments (*P < 0.05).and the phosphorylation of PKC-a that were stimulated by C1P,
respectively. These data, together with the lack of phosphocholine
accumulation after treatment with C1P suggest that SMS is impor-
tant for PKC-a activation and the subsequent stimulation of DNA
synthesis by C1P.
We also found that activation of ERK1-2 and PKB by C1P depend
upon stimulation of PKC-a, as inhibition of this kinase by prolong
treatment (16–18 h) with PMA (Fig. 5A), or with dequalinium
(Fig. 2C and D), blocked both PKB and ERK1-2 phosphorylation
(Fig. 5B–E). These results are consistent with previous reports
showing that PKC-a is upstream of PKB and ERK1-2 activation in
other cell types [26–28]. In addition, the SMS inhibitor D609,BMDMs were pre-incubated for 24 h in 1.5% L-cell conditioned medium. (A) BMDMs
ed with C1P (50 lM) for 15 min. PKC activity was determined using a commercial kit
as fold stimulation relative to control value and are the means ± S.E.M. of three
h with or without PMA (100 nM) prior to addition of C1P (50 lM) for 10 min.
Section 2. Equal loading of protein was monitored using speciﬁc antibodies against
ts. (C) Results of scanning densitometry of the exposed ﬁlms. Data are expressed as
plicate experiments (*P < 0.01). (D) BMDM were treated for 30 min with or without
K 1-2 and PKB was examined by immunoblotting as described in Section 2. Equal
. Similar results were obtained in each of three replicate experiments. (E) Results of
intensity relative to control value and are the means ± S.E.M. of three replicate
Fig. 6. Involvement of SMS activity in C1P-stimulated ERK 1-2 and PKB phosphor-
ylation. BMDMs were pre-incubated for 24 h in 1.5% L-cell conditioned medium. (A)
BMDM were treated with or without D609 (20 lM) for 30 min prior to addition of
C1P (50 lM) for 10 min. Phosphorylation of ERK 1-2 and PKB was examined by
immunoblotting as described in Section 2. Equal loading of protein was monitored
using speciﬁc antibodies against total ERK 1-2 and PKB. Similar results were
obtained in each of two replicate experiments. (B) Results of scanning densitometry
of the exposed ﬁlms. Data are expressed as arbitrary units of intensity relative to
control value and are the means ± S.D. of two replicate experiments.
P. Gangoiti et al. / FEBS Letters 584 (2010) 517–524 523blocked phosphorylation of PKB and ERK1-2 (Fig. 6), thereby sup-
porting the notion that SMS and PKC-a stimulation preceded the
activation of PKB and ERK1-2 in macrophages. In a previous report,
we demonstrated the existence of a plasma membrane Gi protein-
coupled receptor that is speciﬁc for C1P [15]. Also, we demon-
strated that C1P-stimulated cell proliferation requires activation
of PKB and ERK1-2 [8]. However, these actions were not affected
by pertussis toxin (PTX) [15], a potent and well-established inhib-
itor of Gi proteins, suggesting that these effects of C1P were recep-
tor-independent. Likewise, C1P-stimulated macrophage
proliferation was unaltered upon treatment with PTX ([29] and
unpublished work).
Taken together these data demonstrate that PKC-a is a key
enzyme for regulation of cell proliferation by C1P, and that SMS
is required for activation of this PKC isoform by C1P in
macrophages.
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